Cole-Parmer Introduces Digi-Sense Precision Measurement Instruments - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Cole-Parmer Introduces Digi-Sense Precision Measurement Instruments


The Digi-Sense brand offers new technologies that deliver accurate readings while withstanding rigorous use. The new line includes a range of instruments from environmental-testing meters to performance-monitoring equipment, and many of the items are precalibrated to save time, cost, and effort. The product line currently includes 25 models of thermometers, infrared devices, humidity meters, anemometers, light meters, and manometers. Additional products that fill other measurement needs will soon be available. Digi-Sense also features a comprehensive line of temperature probes with customization available for unique applications.

Source: Cole-Parmer

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
70%
Breakthrough designations
4%
Protecting the supply chain
17%
Expedited reviews of drug submissions
2%
More stakeholder involvement
7%
View Results
Eric Langerr Outsourcing Outlook Eric LangerRelationship-building at Top of Mind for Clients
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerRisk Reduction Top Driver for Biopharmaceutical Raw Material Development
Jill Wechsler Regulatory Watch Jill Wechsler Changes and Challenges for Generic Drugs
Faiz Kermaini Industry Insider Faiz KermainiNo Signs of a Slowdown in Mergers
CMOs and the Track-and-Trace Race: Are You Engaged Yet?
Ebola Outbreak Raises Ethical Issues
Better Comms Means a Fitter Future for Pharma, Part 2: Realizing the Benefits of Unified Communications
Better Comms Means a Fitter Future for Pharma, Part 1: Challenges and Changes
Sandoz Wins Biosimilar Filing Race

Click here